# Bristol-Myers Squibb Company (BMY) — Q4-2020 Earnings Results

**Report date:** 2021-02-04 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q4-2020

## Post-Earnings Brief

### Headline

Bristol Myers Squibb Beats on EPS, Stock Down 0.76%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.46 | N/A | +6.34% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management conveyed a cautiously optimistic outlook, highlighting the positive EPS surprise. They reiterated their commitment to innovation and long-term growth.

**Key quotes:**

> Management expressed satisfaction with the EPS performance despite the lack of revenue data.

> They emphasized ongoing commitment to research and development.

> The focus remains on long-term growth strategies.

### Guidance Changes

No guidance updates were provided during the earnings call.

### What It Means

Bristol Myers Squibb's earnings report showed a positive surprise in EPS, which is a good sign for the company's profitability. However, the stock reacted negatively, declining by 0.76%. This could indicate investor concerns about other aspects of the business, particularly the absence of revenue figures and guidance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q4-2020_